ImmunoPrecise Antibodies Ltd.
IPA
$3.20
$0.5721.67%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 206.68% | 92.43% | -41.46% | -44.62% | -58.78% |
| Total Receivables | 6.68% | 0.47% | 4.62% | -32.02% | 0.14% |
| Inventory | -2.58% | -29.90% | -18.30% | -19.54% | 2.45% |
| Prepaid Expenses | -16.08% | -47.73% | -12.49% | -11.51% | -31.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 62.39% | 27.36% | -19.12% | -33.25% | -32.50% |
|
|
|||||
| Total Current Assets | 62.39% | 27.36% | -19.12% | -33.25% | -32.50% |
| Net Property, Plant & Equipment | -6.10% | -14.98% | 34.06% | 27.01% | 58.52% |
| Long-term Investments | 6.49% | -61.02% | -58.29% | -60.11% | -60.44% |
| Goodwill | 6.49% | -61.02% | -58.29% | -60.11% | -60.44% |
| Total Other Intangibles | -95.49% | -96.27% | -20.76% | -24.01% | -24.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.34% | -7.40% | 20.59% | 28.48% | 26.69% |
| Total Assets | -26.31% | -46.51% | -20.96% | -26.26% | -23.93% |
|
|
|||||
| Total Accounts Payable | 29.04% | -27.93% | 31.63% | 82.46% | 61.61% |
| Total Accrued Expenses | -44.60% | 9.78% | 28.14% | -76.73% | -6.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.73% | -11.69% | 73.53% | 46.69% | 38.19% |
| Total Finance Division Other Current Liabilities | -14.63% | 4.57% | -8.21% | 14.34% | 13.99% |
| Total Other Current Liabilities | -14.63% | 4.57% | -8.21% | 14.34% | 13.99% |
| Total Current Liabilities | 10.34% | -9.11% | 64.16% | 65.73% | 35.40% |
|
|
|||||
| Total Current Liabilities | 10.34% | -9.11% | 64.16% | 65.73% | 35.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.17% | -17.70% | 34.92% | 29.13% | 94.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -93.89% | -96.93% | -56.92% | -57.39% | -49.44% |
| Total Liabilities | -14.84% | -34.65% | 15.35% | 10.75% | 19.87% |
|
|
|||||
| Common Stock & APIC | 12.29% | 5.64% | 4.01% | -2.02% | 1.67% |
| Retained Earnings | -29.97% | -42.37% | -32.14% | -27.41% | -33.06% |
| Treasury Stock & Other | 54.01% | 57.61% | 43.12% | 75.53% | -21.93% |
| Total Common Equity | -34.14% | -53.38% | -37.41% | -41.90% | -39.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.14% | -53.38% | -37.41% | -41.90% | -39.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.14% | -53.38% | -37.41% | -41.90% | -39.10% |
|
|
|||||